Replies to post #45266 on Amarin Corp Plc (AMRN)

[rafunrafun]

Thank you. So if exclusivity applies to a drug and not to an indication, even if the judge grants us 5 years and doesn't restart the clock, it'll only be effective until 2017 - so even if REDUCE-IT is stopped early, we'll have to rely on our patents, since we will have under 1 year left of exclusivity.

[HDGabor]

Ajax,

I have two reason to have a good feeling re. patents:
- at least 1 should be valid within the 40+
- the AZN case: they request dismiss, tried to say that Epanova does not infringe the patent - they did not attack the patent itself -> I could not imagine any other reason (since officially they would like to launch E) than the patent is strong enough.

Reset the NCE clock:
I don't have the same good feeling as you, since AMRN was able to market V since 7/26/2012. (Though I hope I'm wrong.)

[biowreck]

Ajax: why complete reduce it if generics can pile on? What protection is afforded to Amarin if 5 year NCE is not granted by the judge?